solaci, Author at SOLACI | Page 423 of 631

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

KISS Trial: provisional stenting in non-left main coronary bifurcations — is less more?

Dr. Omar Tupayachi - 8 May, 2026 0

Coronary bifurcation angioplasty remains one of the most frequent and technically challenging scenarios in interventional cardiology. Between 15% and 20% of coronary procedures involve...

Complex radial access: a four-step protocol to overcome loops and tortuosity

Dr. Juan Manuel Pérez - 7 May, 2026 0

Radial access is currently the preferred strategy for coronary angiography and percutaneous coronary interventions due to its lower rates of bleeding and vascular complications...

Percutaneous closure of paravalvular leaks in high-risk patients: clinical outcomes and the impact of residual leak

Dr. Juan Manuel Pérez - 6 May, 2026 0

Paravalvular leak (PVL) is a relatively frequent complication following valve replacement (overall incidence 5–18%; 2–10% in the aortic position and 7–17% in the mitral...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Artículos del autor

solaci

British Cardiovascular Society

American College of Cardiology

EuroPCR

Cardiovascular Research Foundation (CRF)

American College of Cardiology (ACC)

Sociedad Española de Cardiología (SEC)

Society for Cardiac Angiography and Interventions (SCAI)

European Society of Cardiology (ESC)

Últimas Noticias

KISS Trial: provisional stenting in non-left main coronary bifurcations — is less more?

Complex radial access: a four-step protocol to overcome loops and tortuosity

Percutaneous closure of paravalvular leaks in high-risk patients: clinical outcomes and the impact of residual leak

Noticias Institucionales

Everything You Need to Know About Panama Sessions 2026

Call For Science SOLACI & SBHCI 2026 – Submit Your Work!

FAC Webinar | CTEPH: one disease, three strategies, one team,

Accesos